Notably, we found that neutralizing CXCL10 abolished the tumor-suppressive effects of Smad4 knockdown, indicating that CXCL10 inhibition by Smad4 was crucial for its oncogenic activity (Figure 6G). Here, SMAD4 is linked to neoplasm.